The earnings call reflects a strong quarter for Labcorp with significant revenue growth, increased guidance, and successful new product launches. However, there are concerns about potential future impacts from PAMA and regulatory changes.

Company Guidance

During the Q2 2025 earnings call for Labcorp Holdings, the company provided robust guidance and updates on their strategic initiatives. The call highlighted a 10% year-over-year increase in enterprise revenue, reaching $3.5 billion, with Diagnostics revenue growing by 9% to $2.7 billion and Biopharma Laboratory Services (BLS) revenue up by 11% to $785 million. The company reported a strong quarterly book-to-bill ratio of 1.18, with a trailing 12-month ratio of 1.11. Adjusted earnings per share increased by 10% to $4.35. Labcorp raised its full-year guidance for 2025, with anticipated enterprise revenue growth between 7.5% and 8.6%, adjusted EPS ranging from $16.05 to $16.50, and free cash flow between $1.125 billion and $1.275 billion. The company emphasized ongoing strategic partnerships, acquisitions, and the development of innovative diagnostic tests, particularly in oncology and neurology, as catalysts for sustained growth.

Enterprise Revenue Growth

Enterprise revenue reached $3.5 billion, representing a 10% growth versus last year. Diagnostics revenue grew 9%, reaching $2.7 billion, driven equally by organic growth and acquisitions.

Biopharma Laboratory Services Performance

BLS delivered strong revenue performance and grew 11% or 8% constant currency to $785 million, while margins improved 50 basis points. Central Laboratories grew 8% or 4% constant currency and early development grew 20% or 18% constant currency.

Adjusted Earnings Per Share Increase

Adjusted earnings per share of $4.35 grew 10% year-over-year.

Strong Book-to-Bill Ratio

The quarterly book-to-bill was strong at 1.18 with a trailing 12-month of 1.11.

Launch of Innovative Tests

New tests launched in specialty focus areas, including oncology and Alzheimer's disease. Expanded oncology portfolio with new solutions for cancer detection, diagnosis, and monitoring.

Increased Full Year Guidance

Due to strong performance and favorable forex rates, Labcorp raised its full year guidance for enterprise revenue, adjusted EPS, and free cash flow.

Labcorp Holdings (LH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2025 (Q3)	4.12 / -	3.5	―	―	―
Jul 24, 2025	2025 (Q2)	4.17 / 4.35	3.94	10.41% (+0.41)
Apr 29, 2025	2025 (Q1)	3.74 / 3.84	3.68	4.35% (+0.16)
Feb 06, 2025	2024 (Q4)	3.39 / 3.45	3.3	4.55% (+0.15)
Oct 24, 2024	2024 (Q3)	3.47 / 3.50	3.38	3.55% (+0.12)
Aug 01, 2024	2024 (Q2)	3.78 / 3.94	3.42	15.20% (+0.52)
Apr 25, 2024	2024 (Q1)	3.48 / 3.68	3.282	12.13% (+0.40)
Feb 15, 2024	2023 (Q4)	3.26 / 3.30	3.557	-7.23% (-0.26)
Oct 26, 2023	2023 (Q3)	3.33 / 3.38	4.02	-15.92% (-0.64)
Jul 27, 2023	2023 (Q2)	3.84 / 3.42	4.261	-19.74% (-0.84)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 24, 2025	$249.86	$267.00	+6.86%
Apr 29, 2025	$228.34	$239.10	+4.71%
Feb 06, 2025	$247.91	$245.68	-0.90%
Oct 24, 2024	$217.42	$227.47	+4.62%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Labcorp Holdings (LH) report earnings?

Labcorp Holdings (LH) is schdueled to report earning on Oct 23, 2025, Before Open (Confirmed).

What is Labcorp Holdings (LH) earnings time?

Labcorp Holdings (LH) earnings time is at Oct 23, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LH EPS forecast?

LH EPS forecast for the fiscal quarter 2025 (Q3) is 4.12.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing